Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GENE-THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 5545 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dezawa, M; Takano, M; Negishi, H; Mo, XF; Oshitari, T; Sawada, H
      Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach

      MICRON
    2. Chirila, TV; Rakoczy, PE; Garrett, KL; Lou, X; Constable, IJ
      The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides

      BIOMATERIALS
    3. Molinier-Frenkel, V; Lengagne, R; Gaden, F; Hong, SS; Choppin, J; Gahery-Segard, H; Boulanger, P; Guillet, JG
      Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response

      JOURNAL OF VIROLOGY
    4. Gotsman, I; Israeli, D; Alper, R; Rabbani, E; Engelhardt, D; Ilan, Y
      Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice

      INTERNATIONAL JOURNAL OF CANCER
    5. Merten, OW; Cruz, PE; Rochette, C; Geny-Fiamma, C; Bouquet, C; Goncalves, D; Danos, O; Carrondo, MJT
      Comparison of different bioreactor systems for the production of high titer retroviral vectors

      BIOTECHNOLOGY PROGRESS
    6. Liu, P; Kalajzic, I; Stover, ML; Rowe, DW; Lichtler, AC
      Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation

      BONE
    7. Musgrave, DS; Pruchnic, R; Wright, V; Bosch, P; Ghivizzani, SC; Robbins, PD; Huard, J
      The effect of bone morphogenetic protein-2 expression on the early fate ofskeletal muscle-derived cells

      BONE
    8. Uusitalo, H; Rantakokko, J; Ahonen, M; Jamsa, T; Tuukkanen, J; Kahari, VM; Vuorio, E; Aro, HT
      A metaphyseal defect model of the femur for studies of murine bone healing

      BONE
    9. Hawke, TJ; Garry, DJ
      Myogenic satellite cells: physiology to molecular biology

      JOURNAL OF APPLIED PHYSIOLOGY
    10. Lang, S; Zeidler, R; Pauli, C; Andratschke, M; Wollenberg, B
      Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review.

      LARYNGO-RHINO-OTOLOGIE
    11. Haviv, YS; Blackwell, J
      Transcriptional regulation in cancer gene therapy

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    12. Cohen, ZR; Duvdevani, R; Nass, D; Hadani, M; Ram, Z
      Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    13. Segura, T; Shea, LD
      Materials for non-viral gene delivery

      ANNUAL REVIEW OF MATERIALS RESEARCH
    14. Kaplan, SH; Greenfield, S; Connolly, GA; Barlow, SE; Grand, R
      Methodologic issues in the conduct and interpretation of pediatric effectiveness research

      AMBULATORY PEDIATRICS
    15. Bhardwaj, G; Murdoch, B; Wu, D; Baker, DP; Williams, KP; Chadwick, K; Ling, LE; Karanu, FN; Bhatia, M
      Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation

      NATURE IMMUNOLOGY
    16. Wolff, RA
      Novel therapies for pancreatic cancer

      CANCER JOURNAL
    17. Pfeifer, A; Verma, IM
      Gene therapy: Promises and problems

      ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
    18. Factor, P
      Gene therapy for acute diseases

      MOLECULAR THERAPY
    19. Hartigan-O'Connor, D; Kirk, CJ; Crawford, R; Mule, JJ; Chamberlain, JS
      Immune evasion by muscle-specific gene expression in dystrophic muscle

      MOLECULAR THERAPY
    20. Favre, D; Provost, N; Blouin, V; Blacho, G; Cherel, Y; Salvetti, A; Moullier, P
      Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle

      MOLECULAR THERAPY
    21. Arruda, VR; Fields, PA; Milner, R; Wainwright, L; De Miguel, MP; Donovan, PJ; Herzog, RW; Nichols, TC; Biegel, JA; Razavi, M; Dake, M; Huff, D; Flake, AW; Couto, L; Kay, MA; High, KA
      Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males

      MOLECULAR THERAPY
    22. Williams, JC; Stone, D; Smith-Arica, JR; Morris, ID; Lowenstein, PR; Castro, MG
      Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppressesgrowth of estrogen-induced pituitary prolactinomas

      MOLECULAR THERAPY
    23. Peters, AHFM; Drumm, J; Ferrell, C; Roth, DA; Roth, DM; McCaman, M; Novak, PL; Friedman, J; Engler, R; Braun, RE
      Absence of germline infection in male mice following intraventricular injection of adenovirus

      MOLECULAR THERAPY
    24. Sanftner, LHM; Abel, H; Hauswirth, WW; Flannery, JG
      Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa

      MOLECULAR THERAPY
    25. Rubinchik, S; Wang, D; Yu, H; Fan, F; Luo, M; Norris, JS; Dong, JY
      A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

      MOLECULAR THERAPY
    26. Unsinger, J; Kroger, A; Hauser, H; Wirth, D
      Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes

      MOLECULAR THERAPY
    27. Guibinga, GH; Ebihara, S; Nalbantoglu, J; Holland, P; Karpati, G; Petrof, BJ
      Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice

      MOLECULAR THERAPY
    28. Wu, JC; Sundaresan, G; Iyer, M; Gambhir, SS
      Noninvasive optical imaging of firefly luciferase reporter gene expressionin skeletal muscles of living mice

      MOLECULAR THERAPY
    29. Ko, KS; Lee, M; Koh, JJ; Kim, SW
      Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice

      MOLECULAR THERAPY
    30. Satkauskas, S; Bureau, MF; Mahfoudi, A; Mir, LM
      Slow accumulation of plasmid in muscle cells: Supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis

      MOLECULAR THERAPY
    31. Sanchez-Pernaute, R; Harvey-White, J; Cunningham, J; Bankiewicz, KS
      Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats

      MOLECULAR THERAPY
    32. Richard, E; Mendez, M; Mazurier, F; Morel, C; Costet, P; Xia, P; Fontanellas, A; Geronimi, F; Cario-Andre, M; Taine, L; Ged, C; Malik, P; de Verneuil, H; Moreau-Gaudry, F
      Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection

      MOLECULAR THERAPY
    33. Lipinski, KS; Djeha, AH; Ismail, T; Mountain, A; Young, LS; Wrighton, CJ
      High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue

      MOLECULAR THERAPY
    34. Zhu, YH; Feuer, G; Day, SL; Wrzesinski, S; Planelles, V
      Multigene lentiviral vectors based on differential splicing and translational control

      MOLECULAR THERAPY
    35. Duan, DS; Yue, YP; Engelhardt, JF
      Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison

      MOLECULAR THERAPY
    36. Park, F; Kay, MA
      Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo

      MOLECULAR THERAPY
    37. Nicklin, SA; Buening, H; Dishart, KL; de Alwis, M; Girod, A; Hacker, U; Thrasher, AJ; Ali, RR; Hallek, M; Baker, AH
      Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

      MOLECULAR THERAPY
    38. Sung, MW; Yeh, HC; Thung, SN; Schwartz, ME; Mandeli, JP; Chen, SH; Woo, SLC
      Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial

      MOLECULAR THERAPY
    39. Hemminki, A; Belousova, N; Zinn, KR; Liu, B; Wang, MH; Chaudhuri, TR; Rogers, BE; Buchsbaum, DJ; Siegal, GP; Barnes, MN; Gomez-Navarro, J; Curiel, DT; Alvarez, RD
      An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression

      MOLECULAR THERAPY
    40. Okimoto, T; Friedmann, T; Miyanohara, A
      VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection

      MOLECULAR THERAPY
    41. Honigman, A; Zeira, E; Ohana, P; Abramovitz, R; Tavor, E; Bar, I; Zilberman, Y; Rabinovsky, R; Gazit, D; Joseph, A; Panet, A; Shai, E; Palmon, A; Laster, M; Galun, E
      Imaging transgene expression in live animals

      MOLECULAR THERAPY
    42. Griffith, TS; Broghammer, EL
      Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

      MOLECULAR THERAPY
    43. Inazawa, T; Tanabe, T; Yamada, H; Nakaoka, T; Hashimoto, Y; Yamasaki, T; Kotaki, H; Tani, K; Asano, S; Yamashita, N
      Glucocorticoid-regulated expression of exogenous human growth hormone genein rats

      MOLECULAR THERAPY
    44. Thaler, S; Schnierle, BS
      A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes

      MOLECULAR THERAPY
    45. Peng, HR; Chen, ST; Wergedal, JE; Polo, JM; Yee, JK; Lau, KHW; Baylink, DJ
      Development of an MFG-based retroviral vector system for secretion of highlevels of functionally active human BMP4

      MOLECULAR THERAPY
    46. Puttaraju, M; DiPasquale, J; Baker, CC; Mitchell, LG; Garcia-Blanco, MA
      Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing

      MOLECULAR THERAPY
    47. Boyle, MP; Enke, RA; Adams, RJ; Guggino, WB; Zeitlin, PL
      In utero AAV-mediated gene transfer to rabbit pulmonary epithelium

      MOLECULAR THERAPY
    48. Stoll, SM; Sclimenti, CR; Baba, EJ; Meuse, L; Kay, MA; Calos, MP
      Epstein-Barr virus/human vector provides high-level, long-term expression of alpha(1)-antitrypsin in mice

      MOLECULAR THERAPY
    49. Dhillon, H; Kalra, SP; Kalra, PS
      Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus

      MOLECULAR THERAPY
    50. Chalmers, D; Ferrand, C; Apperley, JF; Melo, JV; Ebeling, S; Newton, I; Duperrier, A; Hagenbeek, A; Garrett, E; Tiberghien, P; Garin, M
      Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene

      MOLECULAR THERAPY
    51. Atencio, IA; Avanzini, JB; Johnson, D; Neuteboom, S; Vaillancourt, MT; Nielsen, LL; Hajian, G; Sutjipto, S; Sugarman, BJ; Philopena, J; McAllister, DL; Beltran, JC; Nodelman, M; Ramachandra, M; Wills, KN
      Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment

      MOLECULAR THERAPY
    52. Croyle, MA; Cheng, X; Sandhu, A; Wilson, JM
      Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo

      MOLECULAR THERAPY
    53. Maron, DJ; Tada, H; Moscioni, AD; Tazelaar, J; Fraker, DL; Wilson, JM; Spitz, FR
      Intra-arterial delivery of a recombinant adenovirus does not increase genetransfer to tumor cells in a rat model of metastatic colorectal carcinoma

      MOLECULAR THERAPY
    54. Koehler, DR; Hannam, V; Belcastro, R; Steer, B; Wen, YX; Post, M; Downey, G; Tanswell, AK; Hu, J
      Targeting transgene expression for cystic fibrosis gene therapy

      MOLECULAR THERAPY
    55. Kyriakides, TR; Hartzel, T; Huynh, G; Bornstein, P
      Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery

      MOLECULAR THERAPY
    56. Stein, CS; Kang, Y; Sauter, SL; Townsend, K; Staber, P; Derksen, TA; Martins, I; Qian, J; Davidson, BL; McCray, PB
      In vivo treatment of hemophilia A and mucopolysaccharidosis type VII usingnonprimate lentiviral vectors

      MOLECULAR THERAPY
    57. Vorup-Jensen, T; Jensen, UB; Liu, H; Kawasaki, T; Uemura, K; Thiel, S; Dagnaes-Hansen, F; Jensen, TG
      Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver

      MOLECULAR THERAPY
    58. Serguera, C; Sarkis, C; Ridet, JL; Colin, P; Moullier, P; Mallet, J
      Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain

      MOLECULAR THERAPY
    59. Nettelbeck, DM; Miller, DW; Jerome, V; Zuzarte, M; Watkins, SJ; Hawkins, RE; Muller, R; Kontermann, RE
      Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105)

      MOLECULAR THERAPY
    60. Yao, QP; Wang, SJ; Glorioso, JC; Evans, CH; Robbins, PD; Ghivizzani, SC; Oligino, TJ
      Gene transfer of p53 to arthritic joints stimulates synovial apoptosis andinhibits inflammation

      MOLECULAR THERAPY
    61. Tan, MQ; Qing, K; Zhou, SZ; Yoder, MC; Srivastava, A
      Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice

      MOLECULAR THERAPY
    62. Chen, XW; Frisina, RD; Bowers, WJ; Frisina, DR; Federoff, HJ
      HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage

      MOLECULAR THERAPY
    63. Grifman, M; Trepel, M; Speece, P; Gilbert, LB; Arap, W; Pasqualini, R; Weitzman, MD
      Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

      MOLECULAR THERAPY
    64. Mesika, A; Grigoreva, I; Zohar, M; Reich, Z
      A regulated, NF kappa B-assisted import of plasmid DNA into mammalian cellnuclei

      MOLECULAR THERAPY
    65. Mazzolini, G; Narvaiza, I; Bustos, M; Duarte, M; Tirapu, I; Bilbao, R; Qian, C; Prieto, J; Melero, I
      alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 atthe periphery of hepatic colon cancer metastases induces VCAM-1 expressionand T-cell recruitment

      MOLECULAR THERAPY
    66. Hecht, N; Pappo, O; Shouval, D; Rose-John, S; Galun, E; Axelrod, JH
      Hyper-IL-6 gene therapy reverses fulminant hepatic failure

      MOLECULAR THERAPY
    67. Sanftner, LHM; Rendahl, KG; Quiroz, D; Coyne, M; Ladner, M; Manning, WC; Flannery, JG
      Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina

      MOLECULAR THERAPY
    68. Zhang, Y; Chirmule, N; Gao, GP; Qian, R; Croyle, M; Joshi, B; Tazelaar, J; Wilson, JM
      Acute cytokine response to systemic adenoviral vectors in mice is mediatedby dendritic cells and macrophages

      MOLECULAR THERAPY
    69. Weiss, DJ; Bonneau, L; Liggitt, D
      Use of perfluorochemical liquid allows earlier detection of gene expression and use of less vector in normal lung and enhances gene expression in acutely injured lung

      MOLECULAR THERAPY
    70. Sung, RS; Qin, LH; Bromberg, JS
      TNF alpha and IFN gamma induced by innate anti-adenoviral immune responsesinhibit adenovirus-mediated transgene expression

      MOLECULAR THERAPY
    71. Akyurek, LM; Nallamshetty, S; Aoki, K; San, H; Yang, ZY; Nabel, GJ; Nabel, EG
      Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo

      MOLECULAR THERAPY
    72. Mackay, IM; Metharom, P; Sloots, TP; Wei, MQ
      Quantitative PCR-ELAHA for the determination of retroviral vector transduction efficiency

      MOLECULAR THERAPY
    73. Ng, P; Beauchamp, C; Evelegh, C; Parks, R; Graham, FL
      Development of a FLP/frt system for generating helper-dependent adenoviralvectors

      MOLECULAR THERAPY
    74. Carmen, IH
      A death in the laboratory: The politics of the Gelsinger aftermath

      MOLECULAR THERAPY
    75. Nakano, K; Todo, T; Chijiiwa, K; Tanaka, M
      Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters

      MOLECULAR THERAPY
    76. Moutsatsos, IK; Turgeman, G; Zhou, SH; Kurkalli, BG; Pelled, G; Tzur, L; Kelley, P; Stumm, N; Mi, S; Muller, R; Zilberman, Y; Gazit, D
      Exogenously regulated stem cell-mediated gene therapy for bone regeneration

      MOLECULAR THERAPY
    77. Gao, CH; Kennedy, S; Ponder, KP
      Lipopolysaccharide potentiates the effect of hepatocyte growth factor uponreplication in lung, thyroid, spleen, and colon in rats in vivo

      MOLECULAR THERAPY
    78. Larocca, D; Jensen-Pergakes, K; Burg, MA; Baird, A
      Receptor-targeted gene delivery using multivalent phagemid particles

      MOLECULAR THERAPY
    79. Sukin, SW; Chhikara, M; Zhu, XH; Ayala, G; Aguilar, LK; Smith, EO; Miles, BJ; Thompson, TC; Kadmon, D; Aguilar-Cordova, E
      In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer

      MOLECULAR THERAPY
    80. Green, ES; Rendahl, KG; Zhou, SZ; Ladner, M; Coyne, M; Srivastava, R; Manning, WC; Flannery, JG
      Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18

      MOLECULAR THERAPY
    81. Maijgren-Steffensson, C; Sonnerborg, A; Vahlne, A; Britton, S; Larsson, S; Ahrlund-Richter, L
      Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1

      MOLECULAR THERAPY
    82. Chhikara, M; Huang, HX; Vlachaki, MT; Zhu, XH; Teh, B; Chiu, KJ; Woo, S; Berner, B; Smith, EO; Oberg, KC; Aguilar, LK; Thompson, TC; Butler, EB; Aguilar-Cordova, E
      Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer

      MOLECULAR THERAPY
    83. Stover, ML; Wang, CKL; McKinstry, MB; Kalajzic, I; Gronowicz, G; Clark, SH; Rowe, DW; Lichtler, AC
      Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice

      MOLECULAR THERAPY
    84. Gautam, A; Densmore, CL; Golunski, E; Xu, B; Waldrep, JC
      Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes

      MOLECULAR THERAPY
    85. Mendoza, GJA; Seidel, NE; Otsu, M; Anderson, SM; Simon-Stoos, K; Herrera, A; Hoogstraten-Miller, S; Malech, HL; Candotti, F; Puck, JM; Bodine, DM
      Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model

      MOLECULAR THERAPY
    86. Chen, RH; Meseck, ML; Woo, SLC
      Auto-regulated hepatic insulin gene expression in type 1 diabetic rats

      MOLECULAR THERAPY
    87. Saeki, Y; Fraefel, C; Ichikawa, T; Breakefield, XO; Chiocca, EA
      Improved helper virus-free packaging system for HSV amplicon vectors usingan ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

      MOLECULAR THERAPY
    88. Hughes, C; Galea-Lauri, J; Farzaneh, F; Darling, D
      Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors

      MOLECULAR THERAPY
    89. Soudais, C; Boutin, S; Kremer, EJ
      Characterization of cis-acting sequences involved in canine adenovirus packaging

      MOLECULAR THERAPY
    90. Koch, PE; Guo, ZS; Kagawa, S; Gu, J; Roth, JA; Fang, B
      Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system

      MOLECULAR THERAPY
    91. Lipshutz, GS; Gruber, CA; Cao, YA; Hardy, J; Contag, CH; Gaensler, KML
      In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression

      MOLECULAR THERAPY
    92. Kuzmin, AI; Galenko, O; Eisensmith, RC
      An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors

      MOLECULAR THERAPY
    93. Zavorotinskaya, T; Albritton, LM
      Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein

      MOLECULAR THERAPY
    94. Ramesh, R; Saeki, T; Templeton, NS; Ji, L; Stephens, LC; Ito, I; Wilson, DR; Wu, Z; Branch, CD; Minna, JD; Roth, JA
      Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

      MOLECULAR THERAPY
    95. Frisella, WA; O'Connor, LH; Vogler, CA; Roberts, M; Walkley, S; Levy, B; Daly, TM; Sands, MS
      Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII

      MOLECULAR THERAPY
    96. Donahue, RE; Sorrentino, BP; Hawley, RG; An, DS; Chen, ISY; Wersto, RP
      Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34(+) cells

      MOLECULAR THERAPY
    97. Wu, XF; He, YK; Falo, LD; Hui, KM; Huang, L
      Regression of human mammary adenocarcinoma by systemic administration of arecombinant gene encoding the hFlex-TRAIL fusion protein

      MOLECULAR THERAPY
    98. Slepushkin, VA; Staber, PD; Wang, GS; McCray, PB; Davidson, BL
      Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains

      MOLECULAR THERAPY
    99. Chen, ZY; Yant, SR; He, CY; Meuse, L; Shen, S; Kay, MA
      Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver

      MOLECULAR THERAPY
    100. Mazurier, F; Geronimi, F; Lamrissi-Garcia, I; Morel, C; Richard, E; Ged, C; Fontanellas, A; Moreau-Gaudry, F; Morey, M; de Verneuil, H
      Correction of deficient CD34(+) cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria

      MOLECULAR THERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/14 alle ore 17:58:08